A new NEJM analysis finds pediatric leucovorin prescriptions rose 700 percent across 2025 after federal officials promoted the drug for autism.
Leucovorin Prescriptions for American Children Rose Sevenfold in One Year as Autism Evidence Grew Weaker, Not Stronger
by | Aug 16, 2026 | Uncategorized | 0 comments

Recent Comments